Zurich, Switzerland

Slobodan Tepic

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Kyon Biotech Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Slobodan Tepic. Retrieved from https://idiyas.com/inventor/slobodan-tepic-v2gk5odi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Slobodan Tepic: Veterinary and Medical Inventions

Introduction

Slobodan Tepic is an inventor associated with Zurich, Switzerland. His patent work spans medical treatment and veterinary orthotics, with 2 patents listed in the provided information.

Latest Patents

One of Tepic’s latest patents concerns an asparaginase-based cancer therapy. It describes an improved preparation and delivery of asparaginase for medical use in humans and animals.

Another patent addresses the treatment of knee disorders in veterinary medicine. It describes an external brace, or orthosis, for joint disorders in dogs and cats, including a hock-joint brace intended to treat cranial cruciate disease in dogs.

Career Highlights

The provided career information associates Tepic with Kyon Biotech AG and W. Andrew Hodge. His listed inventions reflect work across both human and veterinary medicine.

Collaborations

Stephen Bresina and Douglas Beck are identified as Tepic’s coworkers.

Conclusion

Slobodan Tepic’s listed patents focus on therapeutic approaches and veterinary devices, highlighting the range of his invention work in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…